🔗 Permalink

Inventor profile of:

Shirishkumar Kulkarni

City:

Pune

Country:

India

Published Applications:

Last publication date:

2025-03-13

Top Assignees for applications by Shirishkumar Kulkarni

The entities that hold a legal rights for patent applications filed by inventor Kulkarni Shirishkumar:

LUPIN LIMITED 13 Mumbai, Maharashtra, India
LUPIN LIMITED 10 Mumbai, India
LUPIN LTD. 2 Mumbai, India
LUPIN LIMITED 1 Maharashtra, India
LUPIN LIMITED 1 Mumbai 400 098 Maharashtra, India
LUPIN LIMITED (Research Park) 1 Pune, India
Lupin Limited 1 , India
LUPIN LTD. 1 , India
Medicis Pharmaceutical Corporation 1 Scottsdale, AZ United States
LUPIN LIMITED 1 Mumbai, State of Maharashtra, India

Recent patent applications by Kulkarni Shirishkumar

Shirishkumar Kulkarni from Pune, IN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-13

US20250082615A1

Human necessities

SOLID DISPERSION OF RIFAXIMIN

#2 | 2020-12-03

US20200375959A1

Human necessities

SOLID DISPERSION OF RIFAXIMIN

#3 | 2019-06-27

US20190192490A1

Human necessities

RIFAXIMIN READY-TO-USE SUSPENSION

#4 | 2019-01-31

US20190029968A1

Human necessities

Modified release formulation of lacosamide

#5 | 2017-02-02

US20170027863A1

Human necessities

Oral controlled release pharmaceutical compositions of Bepotastine

#6 | 2016-05-19

US20160136141A1

Human necessities

Rifaximin ready-to-use suspension

#7 | 2015-12-03

US20150343070A1

Human necessities

Pharmaceutical compositions for gastrointestinal drug delivery

#8 | 2015-01-15

US20150017242A1

Human necessities

Bilayer Tablet of Dronedarone

#9 | 2014-09-18

US20140274970A1

Human necessities

Controlled release pharmaceutical dosage forms

#10 | 2014-08-07

US20140221414A1

Human necessities

SOLID DISPERSION OF RIFAXIMIN

#11 | 2014-01-09

US20140010883A1

Human necessities

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR

#12 | 2013-12-05

US20130323309A1

Human necessities

Sustained Release Composition of Memantine

#13 | 2013-11-28

US20130317063A1

Human necessities

Oral controlled release pharmaceutical compositions of bepotastine

#14 | 2013-08-08

US20130203721A1

Human necessities

TASTE-MASKED POWDER FOR SUSPENSION COMPOSITIONS OF METHYLPREDNISOLONE

#15 | 2013-06-20

US20130156854A1

Human necessities

Controlled release pharmaceutical compositions of milnacipran

#16 | 2013-06-06

US20130143897A1

Human necessities

ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BLONANSERIN

#17 | 2013-03-21

US20130072512A1

Human necessities

Rifaximin ready-to-use suspension

#18 | 2013-01-24

US20130022654A1

Human necessities

Controlled release pharmaceutical compositions of tapentadol

#19 | 2013-01-03

US20130004545A1

Human necessities

SLOW RELEASE PHARMACEUTICAL COMPOSITIONS OF ILOPERIDONE

#20 | 2012-11-08

US20120283252A1

Human necessities

Process for preparing pharmaceutical ophthalmic compositions

#21 | 2012-08-30

US20120219631A1

Human necessities

Modified release formulation of lacosamide

#22 | 2012-08-23

US20120214833A1

Human necessities

SOLID DISPERSION OF RIFAXIMIN

#23 | 2012-02-02

US20120027855A1

Human necessities

PHARMACEUTICAL COMPOSITIONS FOR GASTROINTESTINAL DRUG DELIVERY

#24 | 2011-05-26

US20110123631A1

Human necessities

Oral compositions of clindamycin

#25 | 2011-01-06

US20110003837A1

Human necessities

MODIFIED RELEASE FORMULATIONS OF HMG COA REDUCTASE INHIBITORS

#26 | 2009-01-29

US20090028940A1

Human necessities

Pharmaceutical compositions of rifaximin

#27 | 2009-01-08

US20090011019A1

Human necessities

Pharmaceutical compositions for gastrointestinal drug delivery

InventorID:

10789 ⎘